Shafe MO, Gumede NM, Nyakudya TT, Chivandi E
(Clinical trials of SFN that were withdrawn are not included in the data presented here.) The conditions with the greatest number of ongoing or previous clinical trials on SFN, including breast cancer and prostate cancer, are shown in Figure 5a
Radevski, F., Peraic, P., Maek, T., Starevi, K., Krezic, I., Pavlov, K., Drmic, D., Kralj, T., Seiwerth, S., Sikiric, P., & Kokot, A
[5] Dean O, Giorlando F, Berk M
As a result, studies in experimental animals show that Citicoline increases levels of all phospholipids in neural membranes - yet the normal, youthful proportions of the various phospholipids are not altered